Valuation: HemaCare Corporation

Market Cap 346M 303M 279M 262M 490M 32.61B 501M 3.36B 1.3B 16.12B 1.3B 1.27B 55.89B P/E 2017
8.18x
P/E 2018 27.6x
Enterprise Value 336M 294M 271M 254M 476M 31.68B 486M 3.26B 1.26B 15.66B 1.26B 1.23B 54.29B EV / Sales 2017
1.29x
EV / Sales 2018 4.03x
Free-Float
94.17%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - 01/01/2003
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-2.86% - - 346M
-0.15%+3.19%+53.40%+49.65% 134B
+1.05%+3.78%+3.60%+32.68% 85.84B
-0.72%+0.53%-5.62%+60.95% 25.72B
+1.13%+7.58%+17.62%+47.29% 22.83B
-0.09%-1.97%-18.15%-25.30% 19.93B
+0.51%+3.47%+7.19%+135.26% 15.84B
+1.67%+3.87%-1.36%+5.66% 14.65B
-0.06%+1.62%+51.02%+119.48% 13.7B
-0.07%+0.39%-14.96%-7.30% 12.5B
Average +0.61%+3.08%+10.30%+46.49% 38.28B
Weighted average by Cap. +0.31%+4.25%+23.05%+44.55%

Financials

2017 2018
Net sales 20.21M 17.72M 16.34M 15.29M 28.68M 1.91B 29.27M 196M 75.97M 942M 75.9M 74.24M 3.27B 28.51M 24.99M 23.04M 21.57M 40.45M 2.69B 41.29M 277M 107M 1.33B 107M 105M 4.61B
Net income 4.43M 3.89M 3.58M 3.35M 6.29M 418M 6.42M 43.05M 16.66M 207M 16.64M 16.28M 716M 4.52M 3.96M 3.65M 3.42M 6.41M 426M 6.54M 43.87M 16.97M 211M 16.96M 16.59M 730M
Net Debt -9.06M -7.94M -7.32M -6.85M -12.85M -855M -13.12M -88M -34.05M -422M -34.02M -33.27M -1.46B -9.9M -8.68M -8M -7.49M -14.04M -934M -14.33M -96.14M -37.2M -461M -37.16M -36.35M -1.6B
Logo HemaCare Corporation
Charles River Laboratories Cell Solutions, Inc. is a cell sourcing provider for developers of cell therapies and basic research. The Company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. It offers a comprehensive and integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Its products and services include Research Models & Services, Discovery Services Safety Assessment, Laboratory Sciences, Cell and Gene Therapy CDMO Solutions, Biologics Testing Solutions, Avian Vaccine Services, QC Microbial Solutions, Scientific & Regulatory Advisory Services, and Scientific Staffing, Training & Operations Support.
Employees
-